Browse > Article
http://dx.doi.org/10.7314/APJCP.2015.16.6.2543

Comparison of Infection between Internal-External and External Percutaneous Transhepatic Biliary Drainage in Treating Patients with Malignant Obstructive Jaundice  

Xu, Chuan (Department of Interventional Radiology, Subei People's Hospital of Jiangsu Province, Clinical Hospital of Yangzhou University)
Huang, Xin-En (Department of Chemotherapy, Jiangsu Cancer Hospital, Nanjing Medical University)
Wang, Shu-Xiang (Department of Interventional Radiology, Subei People's Hospital of Jiangsu Province, Clinical Hospital of Yangzhou University)
Lv, Peng-Hua (Department of Interventional Radiology, Subei People's Hospital of Jiangsu Province, Clinical Hospital of Yangzhou University)
Sun, Ling (Department of Interventional Radiology, Subei People's Hospital of Jiangsu Province, Clinical Hospital of Yangzhou University)
Wang, Fu-An (Department of Interventional Radiology, Subei People's Hospital of Jiangsu Province, Clinical Hospital of Yangzhou University)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.16, no.6, 2015 , pp. 2543-2546 More about this Journal
Abstract
Purpose: Percutaneous transhepatic biliary drainage (PTBD) is a form of palliative care for patients with malignant obstructive jaundice. We here compared the infection incidence between internal-external and external drainage for patients with malignant obstructive jaundice. Methods: Patients with malignant obstructive jaundice without infection before surgery receiving internal-external or external drainage from January 2008 to July 2014 were recruited. According to percutaneous transhepatic cholangiography (PTC), if the guide wire could pass through the occlusion and enter the duodenum, we recommended internal-external drainage, and external drainage biliary drainage was set up if the occlusion was not crossed. All patients with infection after procedure received a cultivation of blood and a bile bacteriological test. Results: Among 110 patients with malignant obstructive jaundice, 22 (52.4%) were diagnosed with infection after the procedure in the internal-external drainage group, whereas 19 (27.9%) patients were so affected in the external drainage group, the difference being significant (p<0.05). In 8 patients (36.3%) in the internal-external group infection was controlled, as compared to 12 (63.1%) in the external group (p< 0.05). The mortality rate for patients with infection not controlled in internal-external group in one month was 42.8%, while this rate in external group was 28.6% (p< 0.05). Conclusion: External drainage is a good choice, which could significantly reduce the chance of biliary infection caused by bacteria, and decrease the mortality rate at one month and improve the long-term prognosis.
Keywords
Internal-external drainage; external drainage; infection incidence; malignant obstructive jaundice;
Citations & Related Records
Times Cited By KSCI : 4  (Citation Analysis)
연도 인용수 순위
1 Boursier J, Cesbron E, Tropet AL, et al (2009). Comparison and improvement of MELD and Child-Pugh score accuracies for the predietion of 6-month mortality in cirrhotic patients. J Clin Gastroenterol, 43, 580-5.   DOI
2 Dambraukas Z, Paskauskas S, Lizdenis P, et al (2003). Percutaneous transhepatic biliary stenting: the first experience and results of the Hospital of Kaunas University of Medicine. Med, 44, 969-76.
3 De Jong EA, Moelker A, Leertouwer T, et al (2013). Percutaneous transhepatic biliary drainage in patients with postsurgical bile leakage and nondilated intrahepatic bile ducts. Dig Surg, 30, 444-50.   DOI   ScienceOn
4 Englesbe MJ, Dawes LG (2005). Resistant pathogen in biliary obstruction: importance of cultures to guide antibiotic therapy. HPB, 7, 144-8.   DOI
5 Herzog T, Belyaev O, Hessam S, et al (2012). Bacteribilia with resistant microorganisms after preoperative biliary drainage the influence of bacteria on postoperative outcome. Scand J Gastroenterol, 47, 827-35.   DOI
6 Ho CS, Warkentin AE (2013). Evidence-based decompression in malignant biliary obstruction. Korean J Radiol, 13, S56-61.
7 Jong Kyoung Choi, Ji Kon Kyu, et al (2013). Palliative treatment of unresectable hepatocellular carcinoma with obstructive jaundice using biliary drainage with subsequent transarterial chemoembolization. J Palliat Med, 16, 1026-33.   DOI   ScienceOn
8 Kawakami H, Kondo S, Kuwatani M, et al (2011). Preoperative biliary drainage for hilar cholangiocarcinoma: which stent should be selected? J Hepatobiliary Pancreat Sci, 18, 630-5.   DOI
9 Kaya M, Bestas R, Bacalan F, et al (2012). Microbial profile and antibiotic sensitivity pattern in bile cultures from endoscopic retrograde cholangiography patients. World J Gastroenterol, 18, 3585-9.   DOI
10 Li Sol Y, Kim CW, Jeon UB, et al (2010). Early infectious complications of percutaneous metallic stent insertion for malignant biliary obstruction. AJR Am J Roentgenol, 194, 261-5.   DOI
11 Lofts FJ, Evans TR, Mansi JL, Glees JP, Knight MJ (1997). Bile duct stents: is there an increased rate of complications in patients receiving chemotherapy? Eur J Cancer, 33, 209-13.   DOI
12 Namias N, Demoya M, Sleeman D, et al (2005). Risk of postoperative infection in patients with bactibilia undergoing surgery for obstructive jaundice. Surg Infect, 6, 323-8.   DOI
13 Ozden I, Tekant Y, Bilge O, et al (2005). Endoscopic and radiologic interventions as the leading causes of severe cholangitis in a tertiary referral center. Am J Surg, 189, 702-6.   DOI
14 Shin Ahn, Yoon-seon Lee, Kyung Soo Lin, et al (2013). Malignant biliary obstructions can we predict immediate postprocedural cholangitis after percutaneous biliary drainage? Support Care Cancer, 21, 2321-6.   DOI   ScienceOn
15 Westwood DA, Fernando C, Connor Sj, et al (2010). external percutaneous transhepatic billary drainage for malignant biliary obstruction: a retrospective analysis. J Med Imag Rad Oncol, 54, 108-10.   DOI   ScienceOn
16 Simmons DT, Baron TH, Petersen BT, et al (2006). A novel endoscopic approach to brachytherapy in the management of Hilar cholangiocarcinoma. Am J Gastroenterol, 64, 1792-96.
17 Thunyaharn N, Promthet S, Wiangnon S, et al (2013). Survival of cholangiocarcinoma patients in northeastern Thailand after supportive treatment. Asian Pac J Cancer Prev, 14, 7029-32.   DOI
18 Todoroki T (2000). Chemotherapy for bile duct carcinoma in the light of adjuvant chemotherapy to surgery. Hepatogastroenterology, 47, 644-9.
19 Xu C, Lv PH, Huang XE, et al (2014). Internal-external percutaneous transhepatic biliary drainage for patients with malignant obstructive jaundice. Asian Pac J Cancer Prev, 15, 9391-4.   DOI
20 Xu C, Lv PH, Huang XE, et al (2014). Analysis of different ways of drainage for obstructive jaundice caused by hilar cholangiocarcinoma. Asian Pac J Cancer Prev, 15, 5617-20.   DOI
21 Xu C, Huang XE, Wang SX, et al (2014). Drainage alone or combined with anti-tumor therapy for treatment of obstructive jaundice caused by recurrence and metastasis after primary tumor resection. Asian Pac J Cancer Prev, 15, 2681-4.   DOI   ScienceOn
22 Zhu HD, Guo JH, Teng GJ, et al (2012). A novel biliary loaded 125 I seeds in patients with malignant biliary obstruction: Preliminary results versus a conventional biliary stent. J Hepatol, 56, 1104-11   DOI   ScienceOn